2 Dividend Stocks to Buy Hand Over Fist in November was originally published by The Motley Fool Their recent issues are nothing to fret over for investors focused on the long game. Avidity Biosciences expands its pipeline to include two new drugs targeting rare genetic cardiomyopathies.

Find out why, despite the issues they've faced, both of these healthcare dividend stocks are attractive to investors focused on the long game. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day.

As oil prices remain volatile around thelatest OPEC+ moves and ongoing demand concerns, all eyes are on the energy sector, especially as investors consider President-elect Trump’s energy policies. While deregulation could favor the energy sector,

S hould a high dividend yield raise a yellow flag for investors? In some cases, yes. But not always. There are select stocks out there with relatively safe dividends that also hap